Found: 16
Select item for more details and to access through your institution.
Vitamin D-Binding Protein.
- Published in:
- Annals of the New York Academy of Sciences, 1988, v. 538, n. 1, p. 49, doi. 10.1111/j.1749-6632.1988.tb48849.x
- By:
- Publication type:
- Article
Importance of Early Phase Insulin Secretion to Intravenous Glucose Tolerance in Subjects with Type 2 Diabetes Mellitus.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2001, v. 86, n. 12, p. 5824, doi. 10.1210/jcem.86.12.8105
- By:
- Publication type:
- Article
Synergistic Effects of Nateglinide and Meal Administration on Insulin Secretion in Patients with Type 2 Diabetes Mellitus.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2000, v. 85, n. 3, p. 1081, doi. 10.1210/jcem.85.3.6446
- By:
- Publication type:
- Article
Mealtime glucose regulation with nateglinide in healthy volunteers: comparison with repaglinide and placebo.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Improved control of mealtime glucose excursions with coadministration of nateglinide and metformin.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Population PK nad PK/PD modelling of microencapsulated octreotide acetate in healthy subjects.
- Published in:
- British Journal of Clinical Pharmacology, 2000, v. 50, n. 6, p. 543, doi. 10.1046/j.1365-2125.2000.00297.x
- By:
- Publication type:
- Article
Clinical pharmacokinetics of nateglinide: a rapidly-absorbed, short-acting insulinotropic agent.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Clinical Pharmacokinetics of Nateglinide.
- Published in:
- Clinical Pharmacokinetics, 2004, v. 43, n. 2, p. 97, doi. 10.2165/00003088-200443020-00003
- By:
- Publication type:
- Article
"Cocktail" Approaches and Strategies in Drug Development: Valuable Tool or Flawed Science?
- Published in:
- Journal of Clinical Pharmacology, 2004, v. 44, n. 2, p. 120, doi. 10.1177/0091270003261333
- By:
- Publication type:
- Article
Tegaserod Pharmacokinetics Are Similar in Patients with Severe Renal Insufficiency and in Healthy Subjects.
- Published in:
- Journal of Clinical Pharmacology, 2003, v. 43, n. 4, p. 359
- By:
- Publication type:
- Article
Pharmacokinetics of Nateglinide in Renally Impaired Diabetic Patients.
- Published in:
- Journal of Clinical Pharmacology, 2003, v. 43, n. 2, p. 163, doi. 10.1177/0091270002239825
- By:
- Publication type:
- Article
The Effects of Tegaserod (HTF 919) on the Pharmacokinetics and Pharmacodynamics of Digoxin in Healthy Subjects.
- Published in:
- Journal of Clinical Pharmacology, 2001, v. 41, n. 10, p. 1131, doi. 10.1177/009127000104101012
- By:
- Publication type:
- Article
Tegaserod Coadministration Does Not Alter the Pharmacokinetics of Theophylline in Healthy Subjects.
- Published in:
- Journal of Clinical Pharmacology, 2001, v. 41, n. 9, p. 987, doi. 10.1177/009127000104100909
- By:
- Publication type:
- Article
Pharmacokinetics, Pharmacodynamics, and Safety of Microencapsulated Octreotide Acetate in Healthy Subjects.
- Published in:
- Journal of Clinical Pharmacology, 2000, v. 40, n. 5, p. 475, doi. 10.1177/009127000004000508
- By:
- Publication type:
- Article
Effect of Meal Timing Not Critical for the Pharmacokinetics of Tegaserod (HTF 919).
- Published in:
- Journal of Clinical Pharmacology, 1999, v. 39, n. 9, p. 911, doi. 10.1177/009127009903900903
- By:
- Publication type:
- Article
The Effect of Food on the Oral Bioavailability and the Pharmacodynamic Actions of the Insulinotropic Agent Nateglinide in Healthy Subjects.
- Published in:
- Journal of Clinical Pharmacology, 1999, v. 39, n. 2, p. 172, doi. 10.1177/009127009903900210
- By:
- Publication type:
- Article